Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brachytherapy dosimetry parameters calculated for a new 103Pd source.

Mark J Rivard1, Christopher S Melhus, Bernadette L Kirk

  • 1Department of Radiation Oncology, Tufts University School of Medicine, Tufts-New England Medical Center, Box #246, 750 Washington Street, Boston, Massachusetts 02111, USA.

Medical Physics
|October 19, 2004
PubMed
Summary

A novel palladium-103 brachytherapy source was developed and characterized. Monte Carlo simulations confirmed its dose distribution aligns with current dosimetry standards, ensuring accurate radiation delivery for cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Redefining the therapeutic landscape of glioblastomas and brain metastasis through cesium brachytherapy and low-kV intra-operative radiation therapy (IORT).

Journal of neuro-oncology·2026
Same author

Investigation of inter-source and intra-source spectral variations in an electronic brachytherapy source using spectral measurements and Monte Carlo simulations.

Medical physics·2026
Same author

Redefining the therapeutic landscape of glioblastomas and brain metastasis through cesium brachytherapy and low-kV intra-operative radiation therapy (IORT).

Journal of neuro-oncology·2025
Same author

Temporal drift in calibration of Ir-192 brachytherapy sources: A multi-center study on dosimetric discrepancies and metrological consistency.

Physics and imaging in radiation oncology·2025
Same author

Investigation of heterogeneity corrections for accelerated Monte Carlo-based treatment planning of plaque ocular brachytherapy.

Brachytherapy·2025
Same author

AAPM medical physics practice guideline 13.a: HDR brachytherapy, part B.

Journal of applied clinical medical physics·2025

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Nuclear Engineering

Background:

  • Brachytherapy is a crucial cancer treatment modality.
  • Accurate dosimetry is essential for effective and safe brachytherapy.
  • New radioactive sources require thorough characterization.

Purpose of the Study:

  • To design and characterize a new brachytherapy source using Palladium-103 (103Pd).
  • To evaluate the dose distributions of the 103Pd source.
  • To present dosimetry parameters according to the AAPM TG-43U1 formalism.

Main Methods:

  • Design of a novel brachytherapy source with 103Pd adsorbed onto silver beads.
  • Utilized MCNP (Monte Carlo N-Particle) version 5 code for radiation transport simulations.
  • Applied the AAPM Task Group No. 43 Update 1 (TG-43U1) formalism for analysis.

Related Experiment Videos

Main Results:

  • Detailed dose distributions for the new 103Pd brachytherapy source were generated.
  • Key dosimetry parameters were calculated and reported.
  • The characterization methodology adheres to established clinical standards.

Conclusions:

  • The designed 103Pd brachytherapy source demonstrates well-defined dose distributions.
  • The characterization provides essential data for clinical implementation.
  • This work supports the use of advanced dosimetry methods in radiation therapy.